Teng Chen

Teng Chen

Auto-generated profile, based on publicly available information

Teng Chen

Department of Applied Mathematics and Statistics, Stony Brook University, Stony Brook, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2020 in Molecular Carcinogenesis
Verified
Journal Article
Open access
PDF file
TCTeng Chen
Teng Chen
JTJulia Y. S. Tsang
Julia Y. S. Tsang
XSXiao‐Chun Su
Xiao‐Chun Su
PLPeng Li
Peng Li
WSWen‐Qin Sun
Wen‐Qin Sun
CMChow Larry Ming-Cheung
Chow Larry Ming-Cheung
Sal‐like protein 4 (SALL4) is overexpressed in breast cancer and might contribute to breast cancer progression, but the molecular mechanism remains unknown. Here, we found that within a group of 371 ethnic Chinese breast cancer patients, SALL4 was associated with lower grade (P = .002) and progesterone receptor positivity (P = .004) for overall cases; lower Ki67 (P = .045) and high vimentin (P = .007) for luminal cases. Patients with high SALL4 expression in lymph node metastasis showed a significantly worse survival than those with low expression. Knockout of SALL4 in a triple‐negative breast cancer cell line MDA‐MB‐231‐Red‐FLuc‐GFP led to suppressed ability in proliferation, clonogenic formation, migration, and mammosphere formation in vitro, tumorigenicity and lung colonization in vivo. On the other hand, overexpression of SALL4 enhanced migration and mammosphere formation in vitro and tumorigenicity in vivo. Mechanistically, there was a positive correlation between SALL4 expression and mesenchymal markers including Zinc finger E‐box binding homeobox 1 (ZEB1), vimentin, Slug, and Snail in vivo. Chromatin immunoprecipitation experiment indicated that SALL4 can bind to the promoter region of vimentin (−778 to −550 bp). Taken together, we hypothesize that SALL4 promotes tumor progression in breast cancer by inducing the mesenchymal markers like vimentin through directly binding to its promoter. Increased SALL4 level in metastatic lymph node relative to the primary site is an important poor survival marker in breast cancer.

16 February 2023 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
XZXingxing Zhang
Xingxing Zhang
JDJing Du
Jing Du
GLGang Li
Gang Li
TCTeng Chen
Teng Chen
JYJin Yang
Jin Yang
Weizhong YangWeizhong Yang
Weizhong Yang
Background: The impact of coronavirus diseases 2019 (COVID-19) related non-pharmaceutical interventions (NPIs) on influenza activity in the presence of other known seasonal driving factors is unclear, especially at the municipal scale. This study aimed to assess the impact of NPIs on outpatient influenza-like illness (ILI) consultations in Beijing and the Hong Kong Special Administrative Region (SAR) of China. Methods: We descriptively analyzed the temporal characteristics of the weekly ILI counts, nine NPI indicators, mean temperature, relative humidity, and absolute humidity from 2011 to 2021. Generalized additive models (GAM) using data in 2011–2019 were established to predict the weekly ILI counts under a counterfactual scenario of no COVID-19 interventions in Beijing and the Hong Kong SAR in 2020–2021, respectively. GAM models were further built to evaluate the potential impact of each individual or combined NPIs on weekly ILI counts in the presence of other seasonal driving factors in the above settings in 2020–2021. Results: The weekly ILI counts in Beijing and the Hong Kong SAR fluctuated across years and months in 2011–2019, with an obvious winter-spring seasonality in Beijing. During the 2020–2021 season, the observed weekly ILI counts in both Beijing and the Hong Kong SAR were much lower than those of the past 9 flu seasons, with a 47.5% [95% confidence interval (CI): 42.3%, 52.2%) and 60.0% (95% CI: 58.6%, 61.1%) reduction, respectively. The observed numbers for these two cities also accounted for only 40.2% (95% CI: 35.4%, 45.3%) and 58.0% (95% CI: 54.1%, 61.5%) of the GAM model estimates in the absence of COVID-19 NPIs, respectively. Our study revealed that, “Cancelling public events” and “Restrictions on internal travel” measures played an important role in the reduction of ILI in Beijing, while the “restrictions on international travel” was statistically most associated with ILI reductions in the Hong Kong SAR. Conclusions: Our study suggests that COVID-19 NPIs had been reducing outpatient ILI consultations in the presence of other seasonal driving factors in Beijing and the Hong Kong SAR from 2020 to 2021. In cities with varying local circumstances, some NPIs with appropriate stringency may be tailored to reduce the burden of ILI caused by severe influenza strains or other respiratory infections in future. Graphical

1 January 2021 in Molecular Cancer Therapeutics
Verified
Journal Article
Closed access
PDF file
PLPeng Li
Peng Li
YHYunjiao He
Yunjiao He
TCTeng Chen
Teng Chen
KCKit Ying Choy
Kit Ying Choy
TCTsun Sing Chow
Tsun Sing Chow
CMChow Larry Ming-Cheung
Chow Larry Ming-Cheung
Staphylococcal nuclease domain-containing protein 1 (SND1) is a multifunctional oncoprotein overexpressed in breast cancer. Binding of metadherin (MTDH) to SND1 results in the stabilization of SND1 and is important in the initiation and progression of breast cancer. Disruption of such interaction is a potential therapeutic for breast cancer. SN1/2 domain of SND1 was used as bait in a phage display screening to identify a 12-amino acid peptide 4-2. The activity of peptide 4-2 was evaluated by ELISA, coimmunoprecipitation, MTS, Western blot analysis, and xenograft mouse model. Peptide 4-2 could disrupt SND1–MTDH interaction. Cell penetrating derivative of peptide 4–2 (CPP-4–2) could penetrate and kill breast cancer cells by disrupting SND1–MTDH interaction and degrading SND1. Tryptophan 10 (W10) of peptide 4-2 was essential in mediating cytotoxicity, SND1 interaction, SND1–MTDH disruption, and SND1 degradation. CPP-4-2 could inhibit the growth of breast cancer in a xenograft mouse model. The SND1-interacting peptide 4-2 could kill breast cancer cells both in vitro and in vivo by interacting with SND1, disrupting SND1–MTDH interaction, and inducing SND1 degradation. W10 was an essential amino acid in the activity of peptide 4-2.

1 June 2007 in Applied Spectroscopy
Verified
Journal Article
Closed access
TCTeng Chen
Teng Chen
JMJohn M. J. Madey
John M. J. Madey
FPFrank M. Price
Frank M. Price
SSShiv K. Sharma
Shiv K. Sharma
BLBarry Lienert
Barry Lienert
This report describes a mobile Raman lidar system that has been developed for spectral measurements of samples located remotely at ranges of hundreds of meters. The performance of this system has been quantitatively verified in a lidar calibration experiment using a hard target of standardized reflectance. A new record in detection range was achieved for remote Raman systems using 532 nm laser excitation. Specifically, Raman spectra of liquid benzene were measured with an integration time corresponding to a single 532 nm laser pulse at a distance of 217 meters. The single-shot Raman spectra at 217 meters demonstrated high signal-to-noise ratio and good resolution sufficient for the unambiguous identification of the samples of interest. The transmitter consists of a 20 Hz Nd:YAG laser emitting at 532 nm and 1064 nm and a 178 mm telescope through the use of which allows the system to produce a focused beam at the target location. The receiver consists of a large custom telescope (609 mm aperture) and a Czerny–Turner monochromator equipped with two fast photomultiplier tubes.

1 January 2021 in Journal of Neurosurgical Sciences
Verified
Journal Article
Closed access
XLXiangli Luo
Xiangli Luo
TCTeng Chen
Teng Chen
KGKang Guan
Kang Guan
KZKe Zhao
Ke Zhao
XQXiaoming Qiu
Xiaoming Qiu
MLMeng Li
Meng Li

4 May 2022 in Journal of Applied Statistics
Verified
Journal Article
Open access
TCTeng Chen
Teng Chen
PPPaweł Polak
Paweł Polak
Stan UryasevStan Uryasev
Stan Uryasev
Early detection and effective treatment of severe COVID-19 patients remain two major challenges during the current pandemic. Analysis of molecular changes in blood samples of severe patients is one of the promising approaches to this problem. From thousands of proteomic, metabolomic, lipidomic, and transcriptomic biomarkers selected in other research, we identify several pairs of biomarkers that after additional nonlinear spline transformation are highly effective in classifying and predicting severe COVID-19 cases. The performance of these pairs is evaluated in-sample, in a cross-validation exercise, and in an out-of-sample analysis on two independent datasets. We further improve our classifier by identifying complementary pairs using hierarchical clustering. In a result, we achieve 96–98% AUC on the validation data. Our findings can help medical experts to identify small groups of biomarkers that after nonlinear transformation can be used to construct a cost-effective test for patient screening and prediction of severity progression.